[<sup>18</sup>F]fluciclovine vs. [<sup>18</sup>F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
Nowadays, there is still no consensus on the most accurate PET radiopharmaceutical to early detect prostate cancer (PCa) relapse. A tailored radiotracer choice based on a specific patient’s profile could ensure prompt disease detection and an improvement in patients management. We aimed to compare t...
Main Authors: | Cristina Ferrari, Paolo Mammucci, Valentina Lavelli, Antonio Rosario Pisani, Anna Giulia Nappi, Dino Rubini, Angela Sardaro, Giuseppe Rubini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Tomography |
Subjects: | |
Online Access: | https://www.mdpi.com/2379-139X/8/6/226 |
Similar Items
-
Texture Analysis in [<sup>18</sup>F]-Fluciclovine PET/CT Aids to Detect Prostate Cancer Biochemical Relapse: Report of a Preliminary Experience
by: Laura Travascio, et al.
Published: (2024-04-01) -
Head-to-Head Comparison of [<sup>18</sup>F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [<sup>18</sup>F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer
by: Laura García-Zoghby, et al.
Published: (2023-06-01) -
Dural Metastases of Advanced Prostate Cancer Detected by <sup>18</sup>F-Fluorocholine
by: Mauro Morassi, et al.
Published: (2020-06-01) -
Comparison of <sup>18</sup>F-fluorothymidine Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
by: Mio Mori, et al.
Published: (2022-10-01) -
[<sup>18</sup>F]fluoride Activation and <sup>18</sup>F-Labelling in Hydrous Conditions—Towards a Microfluidic Synthesis of PET Radiopharmaceuticals
by: Olga Ovdiichuk, et al.
Published: (2023-12-01)